How cadmium exposure affects cancer cell survival and transformation
Cell Survival Advantage in Cadmium Induced Carcinogenesis
This study is looking at how exposure to cadmium might turn normal cells into cancer cells, especially in prostate cancer, and it hopes to find out how this happens so that new treatments can be developed.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas A&m University Health Science Ctr NIH-funded |
| Lab location | 1 site (College Station, United States) |
| Project ID | NIH-10618259 on NIH RePORTER |
What this research studies
This research investigates the effects of cadmium exposure on the transformation of normal cells into cancerous cells, particularly focusing on prostate cancer. It aims to understand the molecular mechanisms involved, including how cadmium induces stress in cells and activates certain pathways that may lead to tumor development. The study will explore the role of autophagy, a process that helps cells manage damage, and how its dysfunction contributes to cancer progression. By examining these processes, the research seeks to uncover potential targets for therapeutic intervention.
Who could benefit from this research
Good fit: Ideal candidates for this research are men who have been exposed to cadmium and are at risk for prostate cancer.
Not a fit: Patients who have not been exposed to cadmium or do not have prostate cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing or treating prostate cancer linked to cadmium exposure.
How similar studies have performed: Previous research has shown a correlation between cadmium exposure and prostate cancer, but the specific mechanisms are still being explored, making this a novel investigation.
Where this research is happening
College Station, United States
- Texas A&m University Health Science Ctr — College Station, United States (Active)
Researchers
- Principal investigator: Damodaran, Chendil — Texas A&m University Health Science Ctr
- Study coordinator: Damodaran, Chendil
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.